Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Christopher F Bell"'
Autor:
Christopher F Bell, Karen Worley, Bernard Rubin, Guillaume Germain, Sean D MacKnight, François Laliberté, Ana Urosevic, Mei Sheng Duh, Andrew Concoff
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 1 (2024)
Objective To investigate the real-world impact of intravenous belimumab treatment among patients with SLE using rheumatoid arthritis-derived disease activity measures and SLE-related laboratory values.Methods This retrospective cohort study used US e
Externí odkaz:
https://doaj.org/article/e9abed443db746488309ce44935f42bb
Autor:
Christopher F Bell, Daniel C Gibbons, Myriam Drysdale, Helen J Birch, Emily J Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S Calay, Arjun Puranik, Tyler E Wagner, John C O'Horo, Raymund R Razonable
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0304822 (2024)
BackgroundTo describe outcomes of high-risk patients with coronavirus disease 2019 (COVID-19) treated with sotrovimab, other monoclonal antibodies (mAbs), or antivirals, and patients who did not receive early COVID-19 treatment. We also evaluate the
Externí odkaz:
https://doaj.org/article/40b9c0a553614aab870c96814abcc136
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Objective The management of systemic lupus erythematosus (SLE) flares can incur substantial healthcare costs. In the phase III BLISS-SC trial, subcutaneous (SC) belimumab 200 mg plus standard therapy was associated with significant reductions in time
Externí odkaz:
https://doaj.org/article/c9526a6e5db64288b6b403ecd95f6e63
Autor:
Hong Kan, Christopher F Bell, Julie Priest, Marni Stott-Miller, Justyna Amelio, Xue Song, Brendan Limone, Virginia Noxon
Publikováno v:
Lupus Science and Medicine, Vol 7, Iss 1 (2020)
ObjectiveTo examine the effects of belimumab initiation on healthcare resource utilisation (HCRU) and costs in SLE.MethodsThis retrospective observational cohort study used healthcare administrative claims data from the IBM MarketScan Commercial Clai
Externí odkaz:
https://doaj.org/article/6747a6d8b20d49a7b4187b00e099f932
Autor:
Phaedra T. Johnson, Christopher F. Bell, John White, Breanna Essoi, Linda Nelsen, Carlyne M. Averell
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background Little is known about how patients and healthcare providers (HCPs) perceive the impact of asthma-related exacerbations. This study examined the impact of asthma-related exacerbations on patients’ lives from these different persp
Externí odkaz:
https://doaj.org/article/15a9d89da0f2474da60a11e935cc69f2
Autor:
Shirley P Huang, Maral DerSarkissian, Yuqian M Gu, Mei Sheng Duh, Min-Jung Wang, John Benson, Jensen Vu, Carlyne Averell, Christopher F Bell
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:365-377
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e03a9a58bd6ebe6892ed00bc305c889
https://doi.org/10.18553/jmcp.2023.29.4.365
https://doi.org/10.18553/jmcp.2023.29.4.365
Publikováno v:
Rheumatology and Therapy. 10:551-562
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b466586c3afaf269f5602c25ce5c369d
https://doi.org/10.1007/s40744-023-00532-6
https://doi.org/10.1007/s40744-023-00532-6
Publikováno v:
Rheumatology and Therapy. 10:447-462
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a8032fca3b76a5e7addb8187d417d4f
https://doi.org/10.1007/s40744-022-00524-y
https://doi.org/10.1007/s40744-022-00524-y
Autor:
Mindy M. Cheng, Carolina Reyes, Sacha Satram, Helen Birch, Daniel C. Gibbons, Myriam Drysdale, Christopher F. Bell, Anvar Suyundikov, Xiao Ding, M. Cyrus Maher, Wendy Yeh, Amalio Telenti, Lawrence Corey
Publikováno v:
Infectious Diseases and Therapy. 12:607-621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68ae1254559fe9eb1e8ecd1d0ab532b5
https://doi.org/10.1007/s40121-022-00755-0
https://doi.org/10.1007/s40121-022-00755-0
Autor:
Nevin Hammam, Michael Evans, Christopher F. Bell, Kerry Gairy, Jinoos Yazdany, Gabriela Schmajuk
Publikováno v:
ACR Open Rheumatology. 4:883-889
Glucocorticoids are part of standard therapy for systemic lupus erythematosus (SLE), despite adverse effects associated with long-term treatment. Belimumab improved clinical manifestations of SLE and reduced glucocorticoid doses in clinical trials an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50adf89c828768c15ecbb272f37f9122
https://doi.org/10.1002/acr2.11482
https://doi.org/10.1002/acr2.11482